Abstract
In patients with rheumatoid arthritis (RA), timely initiation of treatment with disease-modifying antirheumatic drugs is associated with better outcomes.1,2 In many countries, the swiftness of treatment initiation depends highly on timely referral to the rheumatologist by the general practitioner (GP).3